Bruker Corporation (BRKR)
Return on equity (ROE)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 113,100 | 427,200 | 296,600 | 277,100 | 157,800 |
| Total stockholders’ equity | US$ in thousands | 1,781,200 | 1,377,200 | 1,113,800 | 1,070,500 | 961,200 |
| ROE | 6.35% | 31.02% | 26.63% | 25.89% | 16.42% |
December 31, 2024 calculation
ROE = Net income ÷ Total stockholders’ equity
= $113,100K ÷ $1,781,200K
= 6.35%
Bruker Corporation's return on equity (ROE) has fluctuated over the years based on the provided data. In December 31, 2020, the ROE was 16.42%, indicating that for every dollar of shareholders' equity, the company generated a return of 16.42%. The ROE increased significantly to 25.89% by December 31, 2021, and continued to rise to 26.63% by December 31, 2022.
The highest ROE recorded was 31.02% on December 31, 2023, suggesting that the company was efficiently utilizing its equity to generate profits. However, there was a notable decrease in ROE to 6.35% by December 31, 2024, which may indicate a decline in profitability or efficiency in utilizing shareholder equity.
Overall, the trend in ROE shows a mixture of improvements and fluctuations, highlighting the variability in Bruker Corporation's profitability and efficiency in generating returns for its shareholders over the years.
Peer comparison
Dec 31, 2024